Cocultivation of microorganisms as a strategy for discovery of new natural produ...
Cocultivation of microorganisms as a strategy for discovery of new natural products with antimicrobial properties
New antibiotics are urgently needed to combat persistent, emerging and re-emerging infectious diseases. Historically, microbial natural products have been a prolific source of antibacterials, and the screening of microbial extract...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
DiPaC_MC
Direct Pathway Cloning of Neglected Bacteria in the Hunt for...
159K€
Cerrado
FUNBIT
Imaging Mass Spectrometry of Fungal Bacterial Interplay
159K€
Cerrado
ANT
Mining for new antimicrobials in ant associated actinomycete...
210K€
Cerrado
BES-2011-044466
ESTUDIOS SOBRE RECONOCIMIENTO MOLECULAR DE AMINOGLICOSIDOS P...
43K€
Cerrado
SAF2014-56568-R
DESARROLLO DE NUEVOS ANTIMICROBIANOS BASADOS EN EL ESTUDIO D...
Cerrado
BACtheWINNER
Bacteriocins from interbacterial warfare as antibiotic alter...
3M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
New antibiotics are urgently needed to combat persistent, emerging and re-emerging infectious diseases. Historically, microbial natural products have been a prolific source of antibacterials, and the screening of microbial extracts has yielded many classes of antibiotics. However, this approach was largely abandoned by big pharma because of the high rates of rediscovery of known antibiotics, and the general belief that there were very few new antibacterials to be discovered from microbial natural products.
Sequencing of bacterial genomes has changed that view completely. In many bacteria there are far more gene clusters directing the biosynthesis of antibiotic-like metabolites than natural products known to be produced by the organism. These so-called cryptic gene clusters (cryptic because their metabolic products are not known) are often silent (not expressed) under standard laboratory conditions, and can represent up to 80-90% of the secondary metabolite gene clusters in some bacteria.
In recent years we have witnessed an increased in the employment of cocultures (i.e. cocultivation of more than 1 microorganism) as a strategy to discover new natural products by exploiting cross-communication processes mediated by diffusible signalling molecules.
In this project we will carry out an in-depth study of the capacity of this strategy to discover new antibacterials from microbial metabolites. Objectives: a) Cocultivation of microorganisms from an actinomycete-based microbe collection employing a specifically designed dual fermentation system. b) Antibiosis screening of the obtained microbial extracts using modern high-throughput technologies; identification of active extracts c) LC-MS based chemical dereplication of active extracts using in-house and external natural product databases; identification of promising extracts d) Scale-up of active extracts, bioactivity-guided fractionation process to purify active compounds; structural elucidation of active compounds